http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-104618-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-02
filingDate 2000-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a6fb01b42757520ffedc6a38a98d877
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7d7a17bda5e3d1f3e68b51e9e711cc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b062f582e0edaad059dc1b6222c82fb8
publicationDate 2001-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BG-104618-A
titleOfInvention BISULPHATE SALT OF HIV PROTEZE INHIBITOR
abstract The crystalline bisulfate salt has the formula. It has an unexpectedly high degree of solubility / dissolution and oral bioavailability compared to the free basal form of this azeptic HIV protease inhibitor.
priorityDate 1998-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583499

Total number of triples: 26.